Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| TNET | TRINET GROUP INC | United States | $5.31B | 50,563,849 | 71.59% | 28.41% | Net Selling | Net Selling |
| BOWL | BOWLERO CORP | United States | $1.93B | 148,880,520 | 51.53% | 48.47% | Net Selling | |
| IMCR | IMMUNOCORE HOLDINGS PLC | United Kingdom | $2.02B | 50,011,610 | 82.37% | 2.88% | Net Buying | Net Buying |
| SVRA | SAVARA INC | United States | $576.25M | 138,188,891 | 32.64% | 67.36% | Net Buying | Net Selling |
| DAVA | ENDAVA PLC | United Kingdom | $1.50B | 58,300,691 | 58.59% | 0.00% | ||
| ACM | AECOM | United States | $11.67B | 136,127,400 | 80.95% | 19.05% | Net Selling | Net Selling |
| BKR | BAKER HUGHES CO | United States | $32.38B | 997,997,634 | 89.58% | 0.67% | Net Selling | Net Selling |
| PRPL | PURPLE INNOVATION INC | United States | $119.53M | 107,685,377 | 59.07% | 40.93% | Net Selling | Net Selling |
| ANNX | ANNEXON INC | United States | $528.60M | 92,412,866 | 79.12% | 20.88% | Net Buying | Net Buying |
| CRMD | CORMEDIX INC | United States | $279.74M | 54,959,270 | 31.42% | 10.93% | Net Selling | Net Selling |
| SLN | SILENCE THERAPEUTICS PLC | United Kingdom | $913.02M | 131,881,115 | 20.95% | 0.00% | ||
| VKTX | VIKING THERAPEUTICS INC | United States | $6.22B | 110,268,210 | 72.41% | 9.00% | Net Selling | Net Selling |
| DBRG | DIGITALBRIDGE GROUP INC | United States | $2.24B | 173,781,220 | 89.17% | 10.83% | Net Selling | Net Selling |
| CALC | CALCIMEDICA INC | United States | $54.39M | 10,749,065 | 13.65% | 86.35% | Net Buying | Net Buying |
| MCS | MARCUS CORP | United States | $322.19M | 32,154,967 | 85.94% | 14.06% | Net Buying | Net Buying |
| BHVN | BIOHAVEN LTD | United States | $3.10B | 88,291,909 | 79.46% | 20.54% | Net Buying | Net Buying |
| SABS | SAB BIOTHERAPEUTICS INC | United States | $30.64M | 9,229,274 | 6.01% | 93.99% | Net Buying | |
| ABVX | ABIVAX SA | France | $877.86M | 62,928,818 | 37.14% | 0.00% | ||
| APGE | APOGEE THERAPEUTICS INC | United States | $2.57B | 58,456,027 | 89.97% | 10.03% | Net Buying | |
| FTHM | FATHOM HOLDINGS INC | United States | $38.99M | 20,850,770 | 10.31% | 89.69% | Net Selling | Net Buying |
| IHS | IHS HOLDING LTD | United Kingdom | $1.20B | 332,868,000 | 14.42% | 0.00% | ||
| DVN | DEVON ENERGY CORP | United States | $29.78B | 632,000,000 | 71.47% | 8.45% | Net Selling | Net Selling |
| RRX | REGAL REXNORD CORP | United States | $9.48B | 66,518,762 | 97.59% | 2.41% | Net Selling | Net Selling |
| ALIT | ALIGHT INC | United States | $4.20B | 561,490,282 | 74.61% | 25.39% | Net Selling | Net Selling |
| GANX | GAIN THERAPEUTICS INC | United States | $37.73M | 18,051,979 | 10.34% | 1.89% | Net Buying | Net Buying |
| LRMR | LARIMAR THERAPEUTICS INC | United States | $613.78M | 63,802,017 | 53.81% | 46.19% | Net Buying | |
| WVE | WAVE LIFE SCIENCES LTD | Singapore | $722.51M | 122,460,160 | 61.24% | 38.76% | Net Buying | Net Selling |
| CABA | CABALETTA BIO INC | United States | $530.56M | 48,276,522 | 92.36% | 7.64% | Net Buying | |
| INZY | INOZYME PHARMA INC | United States | $295.05M | 61,855,509 | 54.56% | 45.44% | Net Buying | Net Selling |
| BCYC | BICYCLE THERAPEUTICS PLC | United Kingdom | $990.76M | 42,779,030 | 53.87% | 46.13% | Net Selling | Net Selling |
| SLDB | SOLID BIOSCIENCES INC | United States | $300.13M | 38,379,413 | 36.75% | 63.25% | Net Buying | Net Selling |
| PMVP | PMV PHARMACEUTICALS INC | United States | $87.45M | 51,443,488 | 60.81% | 39.19% | Net Buying | |
| FLUT | FLUTTER ENTERTAINMENT PLC | Ireland | $33.18B | 177,569,013 | 48.70% | 0.00% | ||
| PCVX | VAXCYTE INC | United States | $7.82B | 108,795,188 | 85.54% | 14.46% | Net Selling | Net Selling |
| CGEM | CULLINAN THERAPEUTICS INC | United States | $1.32B | 57,634,234 | 49.85% | 50.15% | Net Buying | Net Buying |
| GHI | GREYSTONE HOUSING IMPACT INVESTORS LP | United States | $350.26M | 23,288,781 | 8.96% | 26.15% | Net Selling | Net Buying |
| PHVS | PHARVARIS NV | Netherlands | $861.07M | 53,816,707 | 78.83% | 0.00% | ||
| SRRK | SCHOLAR ROCK HOLDING CORP | United States | $768.03M | 79,754,065 | 61.63% | 38.37% | Net Buying | |
| BTSG | BRIGHTSPRING HEALTH SERVICES INC | United States | $1.92B | 171,320,174 | 48.31% | 51.69% | Net Buying | Net Buying |
| LBPH | LONGBOARD PHARMACEUTICALS INC | United States | $704.12M | 38,880,054 | 97.48% | 0.08% | Net Selling | |
| CATX | PERSPECTIVE THERAPEUTICS INC | United States | $809.42M | 622,629,038 | 39.77% | 19.80% | Net Buying | Net Buying |
| VERU | VERU INC | United States | $132.04M | 146,383,920 | 32.67% | 33.36% | Net Selling | Net Selling |
| IMAB | I-MAB | China | $149.78M | 185,613,662 | 6.49% | 0.00% | ||
| JBL | JABIL INC | United States | $14.12B | 120,597,316 | 63.81% | 36.19% | Net Selling | Net Selling |
| LINC | LINCOLN EDUCATIONAL SERVICES CORP | United States | $340.22M | 31,443,711 | 14.65% | 85.35% | Net Selling | Net Selling |
| OLMA | OLEMA PHARMACEUTICALS INC | United States | $758.46M | 55,933,827 | 73.87% | 26.13% | Net Buying | Net Selling |
| CLDX | CELLDEX THERAPEUTICS INC | United States | $2.28B | 65,910,548 | 84.47% | 15.53% | Net Buying | Net Buying |
| QCRH | QCR HOLDINGS INC | United States | $933.92M | 16,806,279 | 70.35% | 11.12% | Net Buying | Net Buying |
| CNTX | CONTEXT THERAPEUTICS INC | United States | $144.75M | 74,998,312 | 5.25% | 1.54% | ||
| EFSC | ENTERPRISE FINANCIAL SERVICES CORP | United States | $1.43B | 37,491,713 | 73.15% | 19.66% | Net Selling | Net Selling |
| DAWN | DAY ONE BIOPHARMACEUTICALS INC | United States | $1.09B | 87,389,859 | 53.37% | 46.63% | Net Buying | Net Selling |
| DCGO | DOCGO INC | United States | $325.01M | 101,565,541 | 50.80% | 22.04% | Net Selling | Net Buying |
| CALB | CALIFORNIA BANCORP | United States | $173.85M | 8,439,185 | 59.77% | 12.09% | Net Buying | |
| KURA | KURA ONCOLOGY INC | United States | $1.59B | 76,180,620 | 90.98% | 9.02% | Net Buying | Net Selling |
| NKTX | NKARTA INC | United States | $465.79M | 70,467,620 | 64.47% | 35.53% | Net Buying | Net Buying |
| NRIX | NURIX THERAPEUTICS INC | United States | $752.99M | 49,150,794 | 85.20% | 14.80% | Net Selling | Net Selling |
| DCOM | DIME COMMUNITY BANCSHARES INC | United States | $705.75M | 38,970,051 | 76.48% | 11.67% | Net Selling | Net Selling |
| PINE | ALPINE INCOME PROPERTY TRUST INC | United States | $210.07M | 13,623,239 | 56.71% | 8.92% | Net Buying | Net Buying |
| DNTH | DIANTHUS THERAPEUTICS INC | United States | $629.99M | 29,349,469 | 45.66% | 54.34% | Net Buying | |
| INFA | INFORMATICA INC | United States | $8.57B | 299,633,842 | 32.31% | 67.69% | Net Selling | Net Selling |
| CRBU | CARIBOU BIOSCIENCES INC | United States | $169.80M | 90,317,771 | 73.89% | 8.74% | Net Buying | |
| SNDX | SYNDAX PHARMACEUTICALS INC | United States | $1.68B | 84,987,060 | 91.49% | 8.51% | Net Buying | |
| IMVT | IMMUNOVANT INC | United States | $3.71B | 146,053,941 | 45.32% | 54.68% | Net Buying | Net Selling |
| KRRO | KORRO BIO INC | United States | $435.74M | 9,272,987 | 19.69% | 80.31% | Net Buying | Net Buying |
| CELC | CELCUITY INC | United States | $444.40M | 31,230,085 | 70.86% | 14.94% | Net Selling | Net Selling |
| CGTX | COGNITION THERAPEUTICS INC | United States | $79.32M | 40,058,498 | 17.70% | 60.43% | Net Buying | Net Selling |
| MQ | MARQETA INC | United States | $2.76B | 518,112,108 | 59.96% | 4.06% | Net Selling | Net Selling |
| RZLT | REZOLUTE INC | United States | $218.34M | 40,135,147 | 20.69% | 79.31% | Net Buying | Net Buying |
| MYPS | PLAYSTUDIOS INC | United States | $297.92M | 134,804,070 | 29.49% | 43.33% | Net Selling | Net Selling |
| FDMT | 4D MOLECULAR THERAPEUTICS INC | United States | $1.17B | 51,703,412 | 87.28% | 12.72% | Net Selling | Net Buying |
| KYMR | KYMERA THERAPEUTICS INC | United States | $2.10B | 61,358,262 | 73.56% | 26.44% | Net Selling | Net Selling |
| ACRV | ACRIVON THERAPEUTICS INC | United States | $233.43M | 30,876,932 | 46.40% | 53.60% | Net Buying | Net Buying |
| HCAT | HEALTH CATALYST INC | United States | $394.35M | 59,034,936 | 74.92% | 25.08% | Net Selling | Net Selling |
| IVA | INVENTIVA SA | France | $164.16M | 52,115,807 | 9.31% | 0.00% | ||
| CRBP | CORBUS PHARMACEUTICALS HOLDINGS INC | United States | $468.83M | 10,686,693 | 41.06% | 58.94% | Net Buying | Net Buying |
| ATLX | ATLAS LITHIUM CORP | United States | $181.47M | 14,802,025 | 10.97% | 53.59% | Net Buying | Net Selling |
| SKYE | SKYE BIOSCIENCE INC | United States | $280.12M | 28,067,907 | 0.28% | 99.72% | Net Buying | Net Buying |
| TPST | TEMPEST THERAPEUTICS INC | United States | $70.43M | 22,217,265 | 3.52% | 96.48% | ||
| SNSE | SENSEI BIOTHERAPEUTICS INC | United States | $16.80M | 25,080,958 | 9.21% | 71.96% | Net Selling | |
| BOLD | BOUNDLESS BIO INC | United States | $208.97M | 22,254,537 | 65.21% | 23.96% | Net Buying | Net Buying |
| AS | AMER SPORTS INC | Finland | $7.42B | 505,249,607 | 21.18% | 0.00% | ||
| VERV | VERVE THERAPEUTICS INC | United States | $450.06M | 83,965,493 | 64.29% | 35.71% | Net Buying | Net Buying |
| ORIC | ORIC PHARMACEUTICALS INC | United States | $579.83M | 67,422,307 | 74.89% | 25.11% | Net Selling | Net Buying |
| STRO | SUTRO BIOPHARMA INC | United States | $314.91M | 81,794,334 | 65.30% | 18.25% | Net Selling | Net Selling |
| SU | SUNCOR ENERGY INC | Canada | $49.09B | 1,287,014,000 | 67.81% | 0.00% | ||
| RLAY | RELAY THERAPEUTICS INC | United States | $999.54M | 132,741,677 | 72.64% | 27.36% | Net Selling | Net Selling |
| APTO | APTOSE BIOSCIENCES INC | Canada | $14.84M | 16,309,393 | 6.21% | 65.32% | Net Buying | |
| PXLW | PIXELWORKS INC | United States | $59.54M | 57,807,303 | 24.72% | 18.74% | Net Selling | Net Selling |
| ADVM | ADVERUM BIOTECHNOLOGIES INC | United States | $155.68M | 20,756,850 | 40.55% | 59.45% | Net Buying | |
| NOTE | FISCALNOTE HOLDINGS INC | United States | $150.50M | 134,378,449 | 33.59% | 66.41% | Net Selling | Net Selling |
| RANI | RANI THERAPEUTICS HOLDINGS INC | United States | $209.24M | 50,420,315 | 6.18% | 51.39% | Net Buying | |
| STKL | SUNOPTA INC | Canada | $654.15M | 116,604,089 | 54.91% | 45.09% | Net Selling | Net Selling |
| ENGN | ENGENE HOLDINGS INC | Canada | $344.73M | 43,581,331 | 72.24% | 27.76% | Net Buying | Net Buying |
| HTBK | HERITAGE COMMERCE CORP | United States | $485.76M | 61,255,913 | 74.34% | 22.13% | Net Buying | Net Buying |
| GOSS | GOSSAMER BIO INC | United States | $116.50M | 226,218,652 | 85.80% | 14.20% | Net Buying | Net Selling |
| ELEV | ELEVATION ONCOLOGY INC | United States | $193.97M | 54,638,262 | 78.87% | 21.13% | Net Selling | Net Selling |
| EWTX | EDGEWISE THERAPEUTICS INC | United States | $1.60B | 93,398,767 | 85.98% | 14.02% | Net Buying | Net Selling |
| ANRO | ALTO NEUROSCIENCE INC | United States | $334.44M | 26,883,990 | 59.01% | 24.97% | Net Buying | Net Buying |
| NUVL | NUVALENT INC | United States | $5.17B | 64,556,130 | 70.71% | 29.29% | Net Selling | Net Selling |
| FYBR | FRONTIER COMMUNICATIONS PARENT INC | United States | $6.38B | 248,552,000 | 83.67% | 16.33% | Net Buying | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.